Skip to content
The Nexus
DossierENTITY

GlaxoSmithKline

Coverage of GlaxoSmithKline in the Nexus archive.

Earliest in view: Apr 23 · 16:26 UTCMost recent: Apr 29 · 06:12 UTC
Co-mentioned in this coverage
HIVtopic1Cancer Medicinestopic1Londonplace1Jason Aldenperson1Bloombergorganization1Peter Mandelsonperson1Global Counselorganization1TikTokorganization1Palantir Technologiesorganization1Jeffrey Epsteinperson1HM Revenue & Customsorganization1
Recent coverage
  • BUSINESSApr 29 · 06:12 UTCBLOOMBERG
    GSK Profit Beats Estimates on HIV, Cancer Medicines

    GlaxoSmithKline (GSK) reported higher-than-expected profits driven by sales of its HIV and cancer medications. The company's London-based headquarters was highlighted in the article.

  • POLITICSApr 23 · 16:26 UTCTHE GUARDIAN WORLD
    Mandelson’s lobbying firm Global Counsel went bust owing £4.6m, report says

    Peter Mandelson's former consultancy firm Global Counsel collapsed owing £4.6m, including £600,000 in tax debts, after losing clients due to Mandelson's ties to Jeffrey Epstein. The firm, which advised TikTok, Palantir, and GSK, went bust in February 2023.

GlaxoSmithKline · Dossier · The Nexus